Trials / Terminated
TerminatedNCT01226290
Fibroid Ablation Study
Symptom Effectiveness Study of VizAblate™ Intrauterine Ultrasound-Guided RF Ablation (IUUSgRFA) in the Ablation of Uterine Fibroids
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Gynesonics · Industry
- Sex
- Female
- Age
- 28 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to establish the effectiveness and confirm the safety of the VizAblate System in ablating symptomatic uterine fibroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VizAblate System | VizAblate enables a minimally invasive procedure to visualize, target, and ablate uterine fibroids using intrauterine ultrasound and radiofrequency (RF) energy. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2010-10-22
- Last updated
- 2015-04-02
Locations
10 sites across 3 countries: Mexico, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01226290. Inclusion in this directory is not an endorsement.